ARS Pharmaceuticals | ARS: Annual Report to Security Holders
ARS Pharmaceuticals | DEFA14A: Others
ARS Pharmaceuticals | DEF 14A: Definitive information statements
ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tanimoto Sarina
ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lowenthal Richard E
ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tanimoto Sarina
ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lowenthal Richard E
ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tanimoto Sarina
ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lowenthal Richard E
ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tanimoto Sarina
ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lowenthal Richard E
ARS Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(11.3%),Peter Kolchinsky(11.3%), etc.
ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lowenthal Richard E
ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tanimoto Sarina
ARS Pharmaceuticals | 10-K: Annual report
ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lowenthal Richard E
ARS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tanimoto Sarina
ARS Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
ARS Pharmaceuticals | 8-K: ARS Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
No Data